Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 4093870, 9 pages
http://dx.doi.org/10.1155/2016/4093870
Research Article

Plasma Cathepsin S and Cathepsin S/Cystatin C Ratios Are Potential Biomarkers for COPD

1Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
2Department of Respiratory Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
3Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
4Center for General Internal Medicine and Education, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
5Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara-shi, Kanagawa 259-1193, Japan

Received 12 August 2016; Accepted 17 October 2016

Academic Editor: Massimiliano M. Corsi Romanelli

Copyright © 2016 Takahiro Nakajima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Hogg, F. Chu, S. Utokaparch et al., “The nature of small-airway obstruction in chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 350, no. 26, pp. 2645–2653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. W. MacNee and I. Rahman, “Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 5, part 2, pp. S58–S65, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Kasahara, R. M. Tuder, L. Taraseviciene-Stewart et al., “Inhibition of VEGF receptors causes lung cell apoptosis and emphysema,” Journal of Clinical Investigation, vol. 106, no. 11, pp. 1311–1319, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Barnes, “New therapies for chronic obstructive pulmonary disease,” Medical Principles and Practice, vol. 19, no. 5, pp. 330–338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Owen, “Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 3, no. 2, pp. 253–268, 2008. View at Google Scholar · View at Scopus
  6. G.-P. Shi, J. S. Munger, J. P. Meara, D. H. Rich, and H. A. Chapman, “Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease,” Journal of Biological Chemistry, vol. 267, no. 11, pp. 7258–7262, 1992. View at Google Scholar · View at Scopus
  7. P. Geraghty, C. M. Greene, M. O'Mahony, S. J. O'Neill, C. C. Taggart, and N. G. McElvaney, “Secretory leucocyte protease inhibitor inhibits interferon-γ-induced cathepsin S expression,” Journal of Biological Chemistry, vol. 282, no. 46, pp. 33389–33395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Riese, P. R. Wolf, D. Brömme et al., “Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading,” Immunity, vol. 4, no. 4, pp. 357–366, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Wang, T. Zheng, Z. Zhu et al., “Interferon γ induction of pulmonary emphysema in the adult murine lung,” Journal of Experimental Medicine, vol. 192, no. 11, pp. 1587–1599, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Takeyabu, T. Betsuyaku, M. Nishimura et al., “Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema,” European Respiratory Journal, vol. 12, no. 5, pp. 1033–1039, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. G. K. Sukhova, G.-P. Shi, D. I. Simon, H. A. Chapman, and P. Libby, “Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells,” The Journal of Clinical Investigation, vol. 102, no. 3, pp. 576–583, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. A. H. Warfel, D. Zucker-Franklin, B. Frangione, and J. Ghiso, “Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation,” Journal of Experimental Medicine, vol. 166, no. 6, pp. 1912–1917, 1987. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Ishiguro, I. Ohkubo, M. Mizokami, K. Titani, and M. Sasaki, “The use of monoclonal antibodies to define levels of cystatin C in normal human serum,” Hybridoma, vol. 8, no. 3, pp. 303–313, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. P. R. Goddard, E. M. Nicholson, G. Laszlo, and I. Watt, “Computed tomography in pulmonary emphysema,” Clinical Radiology, vol. 33, no. 4, pp. 379–387, 1982. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Minematsu, H. Nakamura, M. Iwata et al., “Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema,” Thorax, vol. 58, no. 7, pp. 623–628, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. E. S. Crawford and E. S. Cohen, “Aortic aneurysm: a multifocal disease,” Archives of Surgery, vol. 117, no. 11, pp. 1393–1400, 1982. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Mussap, M. D. Vestra, P. Fioretto et al., “Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients,” Kidney International, vol. 61, no. 4, pp. 1453–1461, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. G.-P. Shi, G. K. Sukhova, A. Grubb et al., “Cystatin C deficiency in human atherosclerosis and aortic aneurysms,” The Journal of Clinical Investigation, vol. 104, no. 9, pp. 1191–1197, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Zheng, M. J. Kang, K. Crothers et al., “Role of cathepsin S-dependent epithelial cell apoptosis in IFN-γ-induced alveolar remodeling and pulmonary emphysem,” Journal of Immunology, vol. 174, no. 12, pp. 8106–8115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. G. K. Sukhova, B. Wang, P. Libby et al., “Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice,” Circulation Research, vol. 96, no. 3, pp. 368–375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Taleb, R. Cancello, C. Poitou et al., “Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 3, pp. 1042–1047, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Maurer, E. Fiebiger, B. Reininger et al., “Fcε receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation,” Journal of Immunology, vol. 161, no. 6, pp. 2731–2739, 1998. View at Google Scholar · View at Scopus
  23. M. G. Cosio, M. Saetta, and A. Agusti, “Immunologic aspects of chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 360, no. 23, pp. 2396–2454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Zheng, Z. Zhu, Z. Wang et al., “Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema,” Journal of Clinical Investigation, vol. 106, no. 9, pp. 1081–1093, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. H. K. Rokadia and S. Agarwal, “Serum cystatin C and emphysema: results from the National Health and Nutrition Examination Survey,” Lung, vol. 190, no. 3, pp. 283–290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Ischaki, G. Papatheodorou, E. Gaki, I. Papa, N. Koulouris, and S. Loukides, “Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity,” Chest, vol. 132, no. 1, pp. 164–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. P. Liuzzo, S. S. Petanceska, D. Moscatelli, and L. A. Devi, “Inflammatory mediators regulate cathepsin S in macrophages and microglia: a role in attenuating heparan sulfate interactions,” Molecular Medicine, vol. 5, no. 5, pp. 320–333, 1999. View at Google Scholar · View at Scopus
  28. N. Cimerman, P. M. Brguljan, M. Krašovec, S. Šuškovič, and J. Kos, “Circadian and concentration profile of cathepsin S in sera from healthy subjects and asthmatic patients,” Pflugers Archiv, vol. 442, no. 6, supplement 1, pp. R204–R206, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. N. M. Siafakas, P. Vermeire, N. B. Pride et al., “Optimal assessment and management of chronic obstructive pulmonary disease (COPD),” The European Respiratory Journal, vol. 8, no. 8, pp. 1398–1420, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Kim, H. Zhao, A. M. Boriek et al., “Persistent and newly developed chronic bronchitis are associated with worse outcomes in chronic obstructive pulmonary disease,” Annals of the American Thoracic Society, vol. 13, no. 7, pp. 1016–1025, 2016. View at Publisher · View at Google Scholar